FINHUB Insights

ZBH · Q1 FY26 · Mar 31, 2026

Zimmer Biomet Q1 FY26: where the revenue came from and where it went

Zimmer Biomet Q1 FY26: revenue $2.1B (+9% year over year). Net profit $0.2B. Largest cohort Knees $0.8B. The whole income statement as a sankey diagram from the SEC filing.

Period
Mar 31, 2026
Reported
May 1, 2026 10-Q
Sankey diagram of Zimmer Biomet's income statement for Q1 FY26: revenue of $2.1 billion splits into segments and flows out into costs, taxes and net profit.

Tap the diagram to enlarge · figures in billions of dollars

Revenue$2.1B +9% year over year
Gross profit$1.5B 72% margin
Operating profit$0.4B 18% margin
Net profit$0.2B 11% margin

The numbers

All figures in billions of U.S. dollars, for Q1 FY26 (period ends Mar 31, 2026).
ItemValueShare of revenueYear over year
Revenue 2.1 100% +9%
Knees 0.8 38% +5%
SET 0.6 29% +19%
Hips 0.5 24% +6%
Technology and Data Bone Cement… 0.2 10% +15%
Cost of revenue−0.629%
Gross profit1.572% margin+1pp
SG&A−0.841%+1pp
Other−0.314%+0pp
Operating profit0.418% margin+3pp
Tax−0.1
Interest & other costs−0.1
Net profit0.211%+2pp
Filing on EDGAR More quarters of ZBH

Source of the numbers: structured XBRL data from the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.

Older quarters